Literature DB >> 11157909

Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae.

N Fortineau1, L Poirel, P Nordmann.   

Abstract

A Klebsiella pneumoniae strain resistant to cefoxitin and oxyimino-cephalosporins was cultured from a child hospitalized in Paris, France, in 1992. This isolate harboured a beta-lactamase gene located on an approximately 200 kb non-self-transferable plasmid. The beta-lactamase identified, DHA-2, shared 99% amino acid identity with the AmpC enzyme of Morganella morganii. DHA-2 was a point-mutant derivative of DHA-1 identified previously in a Salmonella enteritidis isolate. DHA-2 expression was inducible due to an ampR regulatory gene. This is the first report of an inducible and plasmid-located cephalosporinase from K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157909     DOI: 10.1093/jac/47.2.207

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  29 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid.

Authors:  V Miriagou; L S Tzouvelekis; L Villa; E Lebessi; A C Vatopoulos; A Carattoli; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

5.  Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

6.  First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test.

Authors:  Etienne Ruppé; Philippe Bidet; Charlotte Verdet; Guillaume Arlet; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

7.  First report of Salmonella isolates with the DHA-1 AmpC beta-lactamase in the United Kingdom.

Authors:  E Liebana; M Batchelor; F A Clifton-Hadley; R H Davies; K L Hopkins; E J Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

8.  Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1.

Authors:  Laurent Poirel; Marc Van De Loo; Hedi Mammeri; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.

Authors:  Jing-Jou Yan; Po-Ren Hsueh; Jang-Jih Lu; Feng-Yee Chang; Jainn-Ming Shyr; Jen-Hsien Wan; Yung-Ching Liu; Yin-Ching Chuang; Yi-Chueh Yang; Shih-Ming Tsao; Hsiu-Hung Wu; Li-Shin Wang; Tsuey-Pin Lin; Hsiu-Mei Wu; Hung-Mo Chen; Jiunn-Jong Wu
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

10.  Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.

Authors:  Yohei Doi; Naohiro Shibata; Keigo Shibayama; Kazunari Kamachi; Hiroshi Kurokawa; Keiko Yokoyama; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.